Cargando…

NMR-Based Metabolomic Analysis of Plasma in Patients with Adult Congenital Heart Disease and Associated Pulmonary Arterial Hypertension: A Pilot Study

Patients with unrepaired congenital heart disease (CHD) are prone to pulmonary arterial hypertension (PAH). The ovine pulmonary arterial smooth muscle cells exposed to increased pulmonary blood flow (PBF) exhibited hyperproliferation and metabolic alterations, but the metabolic disorders of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Beizhu, Huang, Caihua, Zhang, Caojin, Lin, Donghai, Wu, Weifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504385/ https://www.ncbi.nlm.nih.gov/pubmed/36144249 http://dx.doi.org/10.3390/metabo12090845

Ejemplares similares

(1)H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats
por: Lin, Taijie, et al.
Publicado: (2016)

Carcinoembryonic antigen levels are increased with pulmonary output in pulmonary hypertension due to congenital heart disease
por: Zi-yang, Yang, et al.
Publicado: (2020)

NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy
por: Kong, Qing, et al.
Publicado: (2022)

NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy
por: Kong, Qing, et al.
Publicado: (2022)

Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases
por: Zhang, Xi, et al.
Publicado: (2016)

The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017)

Pathogenesis of pulmonary hypertension caused by left heart disease
por: Xiao, Mingzhu, et al.
Publicado: (2023)

Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
por: Ma, Runwei, et al.
Publicado: (2022)

NMR-Based Metabolomic Analysis for the Effects of α-Ketoglutarate Supplementation on C2C12 Myoblasts in Different Energy States
por: Li, Yantong, et al.
Publicado: (2021)

NMR-based metabolomic analysis of the effects of alanyl-glutamine supplementation on C2C12 myoblasts injured by energy deprivation
por: Liu, Zhiqing, et al.
Publicado: (2018)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

NMR-Based Metabolomic Analysis for the Effects of Trimethylamine N-Oxide Treatment on C2C12 Myoblasts under Oxidative Stress
por: Zou, Hong, et al.
Publicado: (2022)

Pulmonary Arterial Hypertension Associated with Congenital Heart Disease in Adults over the Age of 40 Years
por: Maurer, Susanne J., et al.
Publicado: (2020)

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
por: Xu, Zhuoyuan, et al.
Publicado: (2021)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease
por: Condliffe, R., et al.
Publicado: (2018)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
por: Lopes, Antonio, et al.
Publicado: (2014)

Metabolomic Heterogeneity of Pulmonary Arterial Hypertension
por: Zhao, Yidan, et al.
Publicado: (2014)

Effect of Dexmedetomidine on Pulmonary Artery Pressure in Children with Congenital Heart Disease and Pulmonary Hypertension
por: Kanchi, Muralidhar, et al.
Publicado: (2020)

Pulmonary hypertension in congenital heart disease
por: Pascall, Emma, et al.
Publicado: (2018)

Metformin added to bosentan therapy in patients with pulmonary arterial hypertension associated with congenital heart defects: a pilot study
por: Liao, Shutan, et al.
Publicado: (2018)

Acute pulmonary artery dissection in an adult with chronic pulmonary hypertension secondary to congenital heart disease: a case report
por: Tomasino, Marco, et al.
Publicado: (2023)

Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease
por: Schuuring, M. J., et al.
Publicado: (2011)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

Healthcare status of adults with pulmonary hypertension due to congenital heart disease
por: Busse, Amely J., et al.
Publicado: (2022)

Metabolomic Profiling of Adults with Congenital Heart Disease
por: Cedars, Ari, et al.
Publicado: (2021)

Pulmonary Hypertension in Adult Congenital Heart Disease in Asia: A Distinctive Feature of Complex Congenital Heart Disease
por: Chiu, Shuenn‐Nan, et al.
Publicado: (2022)

High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension
por: Luo, Dongling, et al.
Publicado: (2020)

Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease
por: Blok, I.M., et al.
Publicado: (2015)

Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review
por: Varela, Daniel L, et al.
Publicado: (2018)

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
por: Maurer, Susanne J., et al.
Publicado: (2023)

Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension
por: Heresi, Gustavo A., et al.
Publicado: (2020)

The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Li, Gang, et al.
Publicado: (2019)

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension
por: Rhodes, Christopher J., et al.
Publicado: (2017)

Plasma untargeted metabolomics with proteinase K discloses phospholipid signature associated with pulmonary arterial hypertension
por: Wawrzyniak, Renata, et al.
Publicado: (2023)

NMR-Based Metabolomic Analysis on the Protective Effects of Apolipoprotein A-I Mimetic Peptide against Contrast Media-Induced Endothelial Dysfunction
por: Jiang, Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q8ttrnmkblun5gi1mi8j9aiikn